Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility

by E. David Crawford, Neal D. Shore, Daniel P. Petrylak, Celestia S. Higano, Charles J. Ryan
Published 2017-05-01

Preliminary Development of a Mindfulness-Based Group Therapy to Expand Couples’ Sexual Intimacy after Prostate Cancer: A Mixed Methods Approach

by Jennifer A. Bossio, PhD, Celestia S. Higano, MD, FACP, Lori A. Brotto, PhD
Published 2021-04-01

Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy.

by Yoshito Hirata, Kai Morino, Koichiro Akakura, Celestia S Higano, Nicholas Bruchovsky, Teresa Gambol, Susan Hall, Gouhei Tanaka, Kazuyuki Aihara
Published 2015-01-01

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer

by Belinda Nghiem, Xiaotun Zhang, Hung-Ming Lam, Lawrence D. True, Ilsa Coleman, Celestia S. Higano, Peter S. Nelson, Colin C. Pritchard, Colm Morrissey
Published 2016-10-01

Clinic Utilization and Characteristics of Patients Accessing a Prostate Cancer Supportive Care Program’s Sexual Rehabilitation Clinic

by Julie Wong, Luke Witherspoon, Eugenia Wu, Sara Sheikholeslami, Wen Liao, Wallace Yuen, Jenna Bentley, Christine Zarowski, Monita Sundar, Stacy Elliott, Celestia S. Higano, Ryan Flannigan
Published 2020-10-01

Review: Cooperative group trials — Southwest Oncology Group (SWOG) innovations in advanced prostate cancer

by Tanya B. Dorff, Cathy M. Tangen, E. David Crawford, Daniel P. Petrylak, Celestia S. Higano, Derek Raghavan, David I. Quinn, Nicholas J. Vogelzang, Ian M. Thompson
Published 2009-09-01

A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors.

by Xiaoyu Qu, Grace Randhawa, Cynthia Friedman, Brenda F Kurland, Lena Glaskova, Ilsa Coleman, Elahe Mostaghel, Celestia S Higano, Christopher Porter, Robert Vessella, Peter S Nelson, Min Fang
Published 2013-01-01

Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.

by Elahe A Mostaghel, Andrew Morgan, Xiaotun Zhang, Brett T Marck, Jing Xia, Rachel Hunter-Merrill, Roman Gulati, Stephen Plymate, Robert L Vessella, Eva Corey, Celestia S Higano, Alvin M Matsumoto, R Bruce Montgomery, Peter S Nelson
Published 2014-01-01

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes.

by Ryan R Gordon, Mengchu Wu, Chung-Ying Huang, William P Harris, Hong Gee Sim, Jared M Lucas, Ilsa Coleman, Celestia S Higano, Roman Gulati, Lawrence D True, Robert Vessella, Paul H Lange, Mark Garzotto, Tomasz M Beer, Peter S Nelson
Published 2014-01-01

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer

by Christine Henzler, Yingming Li, Rendong Yang, Terri McBride, Yeung Ho, Cynthia Sprenger, Gang Liu, Ilsa Coleman, Bryce Lakely, Rui Li, Shihong Ma, Sean R. Landman, Vipin Kumar, Tae Hyun Hwang, Ganesh V. Raj, Celestia S. Higano, Colm Morrissey, Peter S. Nelson, Stephen R. Plymate, Scott M. Dehm
Published 2016-11-01

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase II...

by Joseph M. Unger, Katherine Griffin, Gary W. Donaldson, Karen M. Baranowski, Margorie J. Good, Eunicia Reburiano, Maha Hussain, Paul J. Monk, Peter J. Van Veldhuizen, Michael A. Carducci, Celestia S. Higano, Primo N. Lara, Catherine M. Tangen, David I. Quinn, James L. Wade, III, Nicholas J. Vogelzang, Ian M. Thompson, Jr, Carol M. Moinpour
Published 2018-06-01

Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer

by Chiara Melloni, MD, MHS, Susan F. Slovin, MD, PhD, Allan Blemings, MS, Shaun G. Goodman, MD, MSc, Christopher P. Evans, MD, Jan Nilsson, MD, Deepak L. Bhatt, MD, MPH, Konstantin Zubovskiy, MD, Tine K. Olesen, MS, MBA, Klaus Dugi, MD, Noel W. Clarke, MBBS, ChM, Celestia S. Higano, MD, Matthew T. Roe, MD, MHS
Published 2020-03-01